Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

the chemours company - CC

CC

Close Chg Chg %
19.24 1.56 8.08%

Pre-Market

20.80

+1.56 (8.08%)

Volume: 2.74M

Last Updated:

Nov 21, 2024, 3:59 PM EDT

Trade Now

Company Overview: the chemours company - CC

CC Key Data

Open

$19.31

 Day Range

19.31 - 20.99

52 Week Range

15.10 - 32.65

 Market Cap

$2.88B

Shares Outstanding

149.41M

 Public Float

148.23M

Beta

1.74

 Rev. Per Employee

N/A

P/E Ratio

42.08

 EPS

$0.46

Yield

519.48%

 Dividend

$0.25

EX-DIVIDEND DATE

Nov 15, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.79M

  

CC Performance

1 Week
 
 10.11%
 
1 Month
 
 13.54%
 
3 Months
 
 7.77%
 
1 Year
 
 -21.12%
 
5 Years
 
 29.51%
 

CC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About the chemours company - CC

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

CC At a Glance

The Chemours Co.
1007 Market Street
Wilmington, Delaware 19801
Phone 1-302-773-1000 Revenue 6.03B
Industry Chemicals: Specialty Net Income -238,000,000.00
Sector Process Industries Employees 6,200
Fiscal Year-end 12 / 2024
View SEC Filings

CC Valuation

P/E Current 42.077
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.779
Price to Book Ratio 6.359
Price to Cash Flow Ratio 8.447
Enterprise Value to EBITDA 32.685
Enterprise Value to Sales 1.193
Total Debt to Enterprise Value 0.598

CC Efficiency

Revenue/Employee 972,096.774
Income Per Employee -38,387.097
Receivables Turnover 9.88
Total Asset Turnover 0.759

CC Liquidity

Current Ratio 1.543
Quick Ratio 0.999
Cash Ratio 0.727

CC Profitability

Gross Margin 21.752
Operating Margin -1.444
Pretax Margin -5.276
Net Margin -3.949
Return on Assets -2.995
Return on Equity -25.813
Return on Total Capital -4.726
Return on Invested Capital -4.845

CC Capital Structure

Total Debt to Total Equity 583.311
Total Debt to Total Capital 85.365
Total Debt to Total Assets 52.103
Long-Term Debt to Equity 568.928
Long-Term Debt to Total Capital 83.261
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for The Chemours Company - CC

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
4.97B 6.34B 6.79B 6.03B
Sales Growth
-10.08% +27.69% +7.08% -11.29%
Cost of Goods Sold (COGS) incl D&A
3.90B 4.96B 5.16B 4.72B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
320.00M 317.00M 291.00M 307.00M
Depreciation
313.00M 309.00M 286.00M 297.00M
Amortization of Intangibles
7.00M 8.00M 5.00M 10.00M
COGS Growth
-12.70% +27.07% +3.97% -8.59%
Gross Income
1.06B 1.38B 1.64B 1.31B
Gross Income Growth
+1.04% +29.98% +18.22% -19.82%
Gross Profit Margin
+21.41% +21.80% +24.07% +21.75%
2020 2021 2022 2023 5-year trend
SG&A Expense
620.00M 674.00M 828.00M 1.40B
Research & Development
93.00M 107.00M 118.00M 108.00M
Other SG&A
527.00M 567.00M 710.00M 1.29B
SGA Growth
-1.12% +8.71% +22.85% +68.84%
Other Operating Expense
- - - -
-
Unusual Expense
73.00M 67.00M 7.00M 161.00M
EBIT after Unusual Expense
371.00M 642.00M 800.00M (248.00M)
Non Operating Income/Expense
17.00M 219.00M 104.00M 138.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
23.00M 43.00M 55.00M 45.00M
Interest Expense
209.00M 185.00M 163.00M 208.00M
Interest Expense Growth
+0.48% -11.48% -11.89% +27.61%
Gross Interest Expense
213.00M 190.00M 170.00M 215.00M
Interest Capitalized
4.00M 5.00M 7.00M 7.00M
Pretax Income
179.00M 676.00M 741.00M (318.00M)
Pretax Income Growth
+244.35% +277.65% +9.62% -142.91%
Pretax Margin
+3.60% +10.65% +10.91% -5.28%
Income Tax
(40.00M) 68.00M 163.00M (81.00M)
Income Tax - Current - Domestic
5.00M 72.00M 96.00M 20.00M
Income Tax - Current - Foreign
75.00M 72.00M 47.00M 57.00M
Income Tax - Deferred - Domestic
(98.00M) (75.00M) 6.00M (136.00M)
Income Tax - Deferred - Foreign
(22.00M) (1.00M) 14.00M (22.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
23.00M 43.00M 55.00M 45.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
219.00M 608.00M 578.00M (237.00M)
Minority Interest Expense
- - - 1.00M
-
Net Income
219.00M 608.00M 578.00M (238.00M)
Net Income Growth
+521.15% +177.63% -4.93% -141.18%
Net Margin Growth
+4.41% +9.58% +8.51% -3.95%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
219.00M 608.00M 578.00M (238.00M)
Preferred Dividends
- - - -
-
Net Income Available to Common
219.00M 608.00M 578.00M (238.00M)
EPS (Basic)
1.3298 3.6861 3.7204 -1.5983
EPS (Basic) Growth
+521.49% +177.19% +0.93% -142.96%
Basic Shares Outstanding
164.68M 164.94M 155.36M 148.91M
EPS (Diluted)
1.3165 3.6041 3.6512 -1.5983
EPS (Diluted) Growth
+517.27% +173.76% +1.31% -143.77%
Diluted Shares Outstanding
166.35M 168.70M 158.30M 148.91M
EBITDA
764.00M 1.03B 1.10B 220.00M
EBITDA Growth
+3.66% +34.29% +7.02% -79.96%
EBITDA Margin
+15.38% +16.17% +16.16% +3.65%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 24.778
Number of Ratings 11 Current Quarters Estimate 0.119
FY Report Date 12 / 2024 Current Year's Estimate 1.228
Last Quarter’s Earnings 0.40 Median PE on CY Estimate N/A
Year Ago Earnings 2.82 Next Fiscal Year Estimate 2.312
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 6 9 9
Mean Estimate 0.12 0.44 1.23 2.31
High Estimates 0.20 0.58 1.30 2.65
Low Estimate 0.04 0.37 1.15 1.98
Coefficient of Variance 42.74 17.82 4.11 10.08

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 4
OVERWEIGHT 0 0 0
HOLD 5 6 6
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for The Chemours Company - CC

Date Name Shares Transaction Value
May 13, 2024 Kristine M. Wellman SVP, GC & Corp. Secretary 36,339 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Diane Picho Interim Pres. - Titanium Tech 19,455 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Ron Charles Senior Vice President, People 20,736 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Joseph T. Martinko President, Thermal & Specializ 16,439 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Joseph T. Martinko President, Thermal & Specializ 15,807 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Joseph T. Martinko President, Thermal & Specializ 16,392 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Calderon Gerardo Familiar Pres Advanced Performance Mat 16,439 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Calderon Gerardo Familiar Pres Advanced Performance Mat 15,807 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Calderon Gerardo Familiar Pres Advanced Performance Mat 23,728 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Kristine M. Wellman SVP, GC & Corp. Secretary 21,498 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Kristine M. Wellman SVP, GC & Corp. Secretary 20,671 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Alvenia Scarborough SVP Corp Communications & CBO 26,794 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Denise M. Dignam President & CEO; Director 95,792 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Denise M. Dignam President & CEO; Director 92,108 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Denise M. Dignam President & CEO; Director 75,328 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Matthew S. Abbott Interim CFO 32,879 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Matthew S. Abbott Interim CFO 31,614 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Matthew S. Abbott Interim CFO 46,106 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Pamela F. Fletcher Director 1,454 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 13, 2024 Alvenia Scarborough SVP Corp Communications & CBO 8,219 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

The Chemours Company in the News